Scientists test Custom-Built vaccine to train immune system to fight ovarian cancer
NCT ID NCT05773859
Summary
This study is testing a personalized vaccine for advanced ovarian cancer. The vaccine is made by loading a patient's own tumor material into specialized immune cells (dendritic cells) taken from their blood. The goal is to see if this vaccine, given alongside standard chemotherapy and surgery, can safely train the patient's immune system to recognize and attack their cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radboud University Medical Center
RECRUITINGNijmegen, Gelderland, 6500 HB, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.